At Close: Dec 01, 2023
Insulet to Present at Upcoming Investor Conferences06:00am, Tuesday, 28'th Nov 2023
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)02:17pm, Monday, 27'th Nov 2023
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Insulet (PODD) Up 31.5% Since Q3 Earnings: What's Driving It?01:31pm, Thursday, 23'rd Nov 2023
Insulet (PODD) continues to gain from the strong adoption of Ommipod 5 and market expansion.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar10:31am, Thursday, 23'rd Nov 2023
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)02:17pm, Friday, 10'th Nov 2023
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Wall Street sees these 2023 losers as 2024 opportunities08:05am, Thursday, 09'th Nov 2023
The 2023 version of the U.S.
Surging Earnings Estimates Signal Upside for Insulet (PODD) Stock01:31pm, Wednesday, 08'th Nov 2023
Insulet (PODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Insulet (PODD) Banks on Omnipod for Consistent Market Share Gain09:01am, Tuesday, 07'th Nov 2023
Insulet's (PODD) Omnipod 5 continues to be a driving force behind U.S. and international growth.
Wall Street Analysts Think Insulet (PODD) Could Surge 53.28%: Read This Before Placing a Bet11:17am, Monday, 06'th Nov 2023
The consensus price target hints at a 53.3% upside potential for Insulet (PODD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Insulet (PODD) Q3 Earnings Beat, 2023 Sales Growth View Up11:17am, Monday, 06'th Nov 2023
Insulet's (PODD) third-quarter 2023 revenues increase year over year as a result of continued high demand for Omnipod 5.
Insulet (PODD) stock up 14% on positive earnings and growth forecast12:03pm, Friday, 03'rd Nov 2023
Shares of medical device company Insulet Corporation (NASDAQ: PODD) witnessed a remarkable surge, jumping by 14% on Friday in response to the company's recent earnings report. The substantial increase
Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstood Growth Name.11:04am, Friday, 03'rd Nov 2023
The automated insulin technology developer posts third-quarter revenue of $432.7 million, compared with $340.8 million a year earlier.
Insulet shares rebound after results top estimates08:33am, Friday, 03'rd Nov 2023
Insulet Corp. shares PODD, +1.98% climbed 10% premarket on Friday after the insulin pump maker late Thursday reported third-quarter results that beat expectations and aimed to dispel some investor fea
Insulet Corporation (PODD) Q3 2023 Earnings Call Transcript10:10pm, Thursday, 02'nd Nov 2023
Insulet Corporation (NASDAQ:PODD ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim Hollingshead - President &